http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GT-200100064-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
filingDate 2001-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ca5566eae574585b0cb3b6d209fa0fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60074af65879125b82b32a28b751d8d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_796c691d3bdbcd091ef71694e014c4c8
publicationDate 2002-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GT-200100064-A
titleOfInvention SODIUM EXCHANGER INHIBITOR - TYPE 1 HYDROGEN.
abstract THE PRESENT INVENTION IS ABOUT AN NHE1 INHIBITOR, METHODS FOR USING THE NHE1 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINED BY THE NHE1 INHIBITOR, THE NHE1 INHIBITOR IS USEFUL FOR REDUCING THE TISSULAR TISSULAR INJURIES. THE PHARAMCEUTICAL COMPOSITIONS OF THE PRESENT INVENTION HAVE APPLICATION IN THE TREATMENT OF CARDIOVASCULAR DISEASES, ARTEROSCLEROSIS, HYPERTENSION, ARRITHMIA, ANGINA OF CHEST, HYPERTROPHY CADIACA, RENAL DISEASES, CANCER ETC.
priorityDate 2000-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553

Total number of triples: 32.